Literature DB >> 25271015

Acute effects of plant stanol esters on postprandial metabolism and its relation with changes in serum lipids after chronic intake.

E De Smet1, R P Mensink1, D Lütjohann2, J Plat1.   

Abstract

BACKGROUND/
OBJECTIVES: Plant stanol esters lower serum low-density lipoprotein (LDL)-cholesterol (LDL-C), but responses between individuals vary widely. As the ability of subjects to respond to acute dietary challenges may reflect the flexibility to adapt to changes on the longer term, we related subjects' acute postprandial metabolic changes to changes in serum lipoproteins after chronic intake of plant stanol esters. SUBJECTS/
METHODS: In a double-blind crossover design, 20 healthy subjects received in random order a high-fat shake enriched with or without plant stanol esters (4 g). Blood samples were taken during 4 h to examine lipid, glucose and lipoprotein profiles. Two subjects dropped out. For the 3 weeks after this postprandial test, the subjects who received the shake with plant stanol esters continued the consumption of plant stanol-enriched (3g/day) margarine and subjects receiving the control shake in the postprandial test consumed for the next 3 weeks a control margarine. After the washout period, subjects received the other shake and margarines.
RESULTS: The margarine enriched with plant stanol esters lowered concentrations of total cholesterol by 7.3% (P<0.01), LDL-C by 9.5% (P<0.01) and apoB100 by 8.6% (P<0.01). Furthermore, particle concentrations of total very low-density lipoprotein (VLDL), small VLDL and large LDL were reduced by 26.6% (P=0.02), 27.6% (P=0.02) and 12.3% (P=0.04), respectively. Plant stanol esters did not affect parameters related to lipid and glucose metabolism during the postprandial phase. However, the incremental area under the curve (iAUC) of the postprandial glucose concentration after consuming the control shake correlated positively with changes in fasting concentrations of total cholesterol, LDL-C, apoB100, total VLDL, small VLDL and intermediate-density lipoprotein after 3 weeks.
CONCLUSIONS: A single dose of plant stanol esters does not change postprandial lipid and lipoprotein profiles. However, postprandial glucose responses may predict the effects of chronic plant stanol ester consumption.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25271015     DOI: 10.1038/ejcn.2014.200

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  29 in total

1.  Effect of stanol ester on postabsorptive squalene and retinyl palmitate.

Authors:  H Relas; H Gylling; T A Miettinen
Journal:  Metabolism       Date:  2000-04       Impact factor: 8.694

Review 2.  Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present.

Authors:  Els De Smet; Ronald P Mensink; Jogchum Plat
Journal:  Mol Nutr Food Res       Date:  2012-05-24       Impact factor: 5.914

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 4.  Metabolic and genetic factors modulating subject specific LDL-C responses to plant sterol therapy.

Authors:  Todd C Rideout; Scott V Harding; Dylan S Mackay
Journal:  Can J Physiol Pharmacol       Date:  2012-04-17       Impact factor: 2.273

Review 5.  Plant sterols and stanols in the treatment of dyslipidemia: new insights into targets and mechanisms related to cardiovascular risk.

Authors:  Sabine Baumgartner; Ronald P Mensink; Jogchum Plat
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8.

Authors:  Knut E Berge; Klaus von Bergmann; Dieter Lutjohann; Rudy Guerra; Scott M Grundy; Helen H Hobbs; Jonathan C Cohen
Journal:  J Lipid Res       Date:  2002-03       Impact factor: 5.922

7.  Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine.

Authors:  S C Thuluva; M Igel; U Giesa; D Lütjohann; T Sudhop; K von Bergmann
Journal:  Int J Clin Pharmacol Ther       Date:  2005-07       Impact factor: 1.366

8.  Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake.

Authors:  Isabelle Demonty; Rouyanne T Ras; Henk C M van der Knaap; Guus S M J E Duchateau; Linsie Meijer; Peter L Zock; Johanna M Geleijnse; Elke A Trautwein
Journal:  J Nutr       Date:  2008-12-17       Impact factor: 4.798

9.  Progress and prospective of plant sterol and plant stanol research: report of the Maastricht meeting.

Authors:  J Plat; D Mackay; S Baumgartner; P M Clifton; H Gylling; P J H Jones
Journal:  Atherosclerosis       Date:  2012-09-24       Impact factor: 5.162

10.  Responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes: a randomized trial.

Authors:  Susan J van Dijk; Marco Mensink; Diederik Esser; Edith J M Feskens; Michael Müller; Lydia A Afman
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more
  5 in total

Review 1.  Progress and perspectives in plant sterol and plant stanol research.

Authors:  Peter J H Jones; Maryam Shamloo; Dylan S MacKay; Todd C Rideout; Semone B Myrie; Jogchum Plat; Jean-Baptiste Roullet; David J Baer; Kara L Calkins; Harry R Davis; P Barton Duell; Henry Ginsberg; Helena Gylling; David Jenkins; Dieter Lütjohann; Mohammad Moghadasian; Robert A Moreau; David Mymin; Richard E Ostlund; Rouyanne T Ras; Javier Ochoa Reparaz; Elke A Trautwein; Stephen Turley; Tim Vanmierlo; Oliver Weingärtner
Journal:  Nutr Rev       Date:  2018-10-01       Impact factor: 7.110

Review 2.  Phytosterols, Phytostanols, and Lipoprotein Metabolism.

Authors:  Helena Gylling; Piia Simonen
Journal:  Nutrients       Date:  2015-09-17       Impact factor: 5.717

3.  Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study.

Authors:  Elke A Trautwein; Wieneke P Koppenol; Arienne de Jong; Harry Hiemstra; Mario A Vermeer; Manny Noakes; Natalie D Luscombe-Marsh
Journal:  Nutr Diabetes       Date:  2018-05-25       Impact factor: 5.097

4.  Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals.

Authors:  Hiroshi Yoshida; Hayato Tada; Kumie Ito; Yoshimi Kishimoto; Hidekatsu Yanai; Tomonori Okamura; Katsunori Ikewaki; Kyoko Inagaki; Tetsuo Shoji; Hideaki Bujo; Takashi Miida; Masayuki Yoshida; Masafumi Kuzuya; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2019-09-05       Impact factor: 4.928

Review 5.  Diversity of Plant Sterols Metabolism: The Impact on Human Health, Sport, and Accumulation of Contaminating Sterols.

Authors:  Arthur T Kopylov; Kristina A Malsagova; Alexander A Stepanov; Anna L Kaysheva
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.